合縱科技(300477.SZ):擬向建設銀行申請綜合授信不超1.5億元
格隆匯9月25日丨合縱科技(300477.SZ)公佈,公司於2020年9月25日召開了第五屆董事會第三十七次會議,審議通過了《關於公司擬向中國建設銀行股份有限公司北京中關村分行申請綜合授信不超過1.5億元的議案》。
結合公司生產經營資金需求的實際情況,為能及時滿足公司業務開展對營運資金的需求,公司擬向建設銀行北京中關村分行申請綜合授信,授信額度不超過1.5億元,期限為1年,具體業務為流動資金貸款、保函、供應鏈業務,由公司全資子公司北京合縱實科電力科技有限公司和天津合縱電力設備有限公司提供連帶責任保證擔保。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.